> IVD Test Reagent/Kits, Molecular Assay, Infection, Bacteria, Treponema Species
IVD Test Reagent/Kits, Molecular Assay, Infection, Bacteria, Treponema Species
Definition : Molecular assay reagents intended to identify species of Treponema, a genus of bacteria of the family Spirochaetaceae, by detecting specific genetic information of the nucleic acid of the target bacteria. Some species of these bacteria cause syphilis; others may cause oral infections or pinta (carate).
Entry Terms : "Pinta Diagnostic Reagents" , "Syphilis Diagnostic Reagents" , "Reagents, Sexually Transmitted Disease" , "Reagents, Molecular Assay, Infection, Bacteria, Treponema Species"
UMDC code : 21702
Our newly expanded portfolio of market-leading lab services can provide your high-performance lab with a comprehensive suite of services, or just the ones you want. From business consulting and protocol development, to instrument repair and optimization, our services can help you increase your lab's productivity and efficiency.
Focus Diagnostics Inc
As part of the Quest Diagnostics family, Focus Diagnostics, Inc. is committed to providing proven and reliable products its customers have grown accustomed to throughout the years. Since its founding in 1978, Focus Diagnostics has grown its business from specialized laboratory testing to manufacturing its high-quality laboratory tests for hospitals and commercial laboratories worldwide. These manufactured tests are built in response to diagnostic testing trends identified and evaluated by Focus Diagnostics and used in Quest Diagnostics' national laboratories.
Gen-Probe is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility.
Gen-Probe Life Sciences Ltd
Gen-Probe Life Sciences Ltd
Innogenetics NV is an international diagnostic company that develops and markets diagnostic products to improve therapy management and patient health.
Somagen Diagnostics Inc
Somagen Diagnostic Inc
Zeus Scientific Inc
ZEUS Scientific is a privately held corporation that was founded in 1976. The company began producing IFA (immunofluorescence assay) test systems followed ELISA and now multiplex (AtheNA Multi-Lyte) immunoassays.
New products are developed to expand the menu which allows laboratories to run an increasing number of assays with common protocols and common reagents, as well as developing new tests to more accurately diagnose patients. In 1987 ZEUS Scientific was the first company to develop, receive appropriate regulatory clearance and bring to market a serological assay to test for Lyme disease – a condition with high prevalence in the local community where ZEUS Scientific is located.